CLOVER CORPORATION LIMITED (CLV)
Share Price Analysis and Chart
Enter the company code or Name for stock analysis:

CLV - CLOVER CORPORATION LIMITED
FNArena Sector :
Health & Nutrition
Year End: July
GICS Industry Group : Health Care Equipment & Services
Index: ALL-ORDS
FNArena Sector : Health & Nutrition
Year End: July
LAST PRICE | CHANGE +/- | CHANGE % | VOLUME |
---|---|---|---|
$1.32
25 May |
0.000 OPEN $1.30 |
0.000 HIGH $1.32 |
33,866 LOW $1.26 |
TARGET | |||||
|
|||||
Franking for last dividend paid out: 100% |
OTHER COMPANIES IN THE SAME SECTOR | |||
EBO . MCP . API . BKL . EXL . SIG . |
FNARENA'S MARKET CONSENSUS FORECASTS
Title | FY20 Actual |
FY21 Actual |
FY22 Forecast |
FY23 Forecast |
---|---|---|---|---|
EPS (cps) | xxx | 3.6 | 4.1 | xxx |
DPS (cps) | xxx | 1.0 | 1.5 | xxx |
EPS Growth | xxx | - 51.9% | 13.6% | xxx |
DPS Growth | xxx | - 60.0% | 50.0% | xxx |
PE Ratio | xxx | N/A | 32.2 | xxx |
Dividend Yield | xxx | N/A | 1.1% | xxx |
Div Pay Ratio(%) | xxx | 27.7% | 36.6% | xxx |
Last ex-div: 06/04 - ex-div 0.5c (franking 100%)
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2022 FactSet UK Limited. All rights reserved
Title | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
---|---|---|---|---|---|---|
EPS Basic | xxx | xxx | xxx | xxx | xxx | 3.6 |
DPS All | xxx | xxx | xxx | xxx | xxx | 1.0 |
Sales/Revenue | xxx | xxx | xxx | xxx | xxx | 60.5 M |
Book Value Per Share | xxx | xxx | xxx | xxx | xxx | 35.1 |
Net Operating Cash Flow | xxx | xxx | xxx | xxx | xxx | 8.2 M |
Net Profit Margin | xxx | xxx | xxx | xxx | xxx | 9.92 % |
EPS Basic
DPS All
Sales/Revenue
Book Value Per Share
Net Operating Cash Flow
Net Profit Margin
Title | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
---|---|---|---|---|---|---|
Return on Capital Employed | xxx | xxx | xxx | xxx | xxx | 10.35 % |
Return on Invested Capital | xxx | xxx | xxx | xxx | xxx | 8.50 % |
Return on Assets | xxx | xxx | xxx | xxx | xxx | 7.49 % |
Return on Equity | xxx | xxx | xxx | xxx | xxx | 10.35 % |
Return on Total Capital | xxx | xxx | xxx | xxx | xxx | 13.15 % |
Free Cash Flow ex dividends | xxx | xxx | xxx | xxx | xxx | 1.4 M |
Return on Capital Employed
Return on Invested Capital
Return on Assets
Return on Equity
Return on Total Capital
Free Cash Flow ex dividends
This is work in progress. Bear with us. It'll be amazing.
EXPERT VIEWS
Display All Commentary
Sentiment Indicator
No. Of Recommendations
CLV STOCK CHART

FNArena News on CLV
1 |
Weekly Ratings, Targets, Forecast Changes – 18-03-22Mar 21 2022 - Weekly Reports |
2 |
FNArena Corporate Results Monitor – 18-03-2022Mar 18 2022 - Australia |
3 |
Rudi’s View: Double Your ProtectionMar 17 2022 - Rudi's View |
4 |
Rudi’s View: The Market Has A CarrotSep 30 2021 - Rudi's View |
5 |
FNArena Corporate Results Monitor – 24-09-2021Sep 24 2021 - Australia |
Latest Health & Nutrition News
1 |
Sigma Healthcare: Brokers WaryMar 31 2022 - Australia |
2 |
Health & Wellness Boom On The ASXApr 29 2021 - Weekly Reports |
3 |
M&A Now On Sigma Healthcare’s AgendaMar 24 2021 - Australia |
4 |
McPherson’s Expands Into Herbal HealthNov 04 2020 - Small Caps |
5 |
Nine Ignored Companies Now Worth A LookSep 23 2020 - FYI |
6 |
Next Week At A Glance – 14-18 Sep 2020Sep 11 2020 - Weekly Reports |
7 |
Sigma Farewells API, Heralds New ContractDec 17 2019 - Australia |
8 |
Blackmores: Hopes Pinned On RestructuringNov 01 2019 - Australia |
9 |
Blackmores Peps Up Its Strategy For ChinaApr 17 2019 - Australia |
10 |
API/Sigma Merger Plan Rears, AgainDec 17 2018 - Australia |